Lisdexamfetamine, marketed as Vyvanse, is a prescription medication approved for attention deficit hyperactivity disorder in youngsters and grown-ups . In Canada, its distribution is managed by Health https://apo-lisdexamfetamine-pri699481.blog93.com/61723932/lisdexamfetamine-in-canada-a-detailed-guide